2 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow ZMapp: new trials by email Literature Review of ZMapp trials Research Report on ZMapp
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigational Therapeutics for the Treatment of People With Ebola Virus Disease ZMapp, Remdesivir, MAb114 - Ebola Virus | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 681 | 2018-11-21 | 2021-09-08 |
| Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection B/Current Standard of Care Plus ZMapp, A/Current Standard of Care Alone - Ebola Virus Infection | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | 2015-03-13 | 2019-06-05 |
| Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers ZMAPP - Healthy | Phase 1 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-11 | 2019-12-16 |
Hemorrhagic Fever, Ebola (2) · Hemorrhagic Fevers, Viral (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3)
United States (2) · Democratic Republic of the Congo (1) · Guinea (1) · Liberia (1) · Sierra Leone (1)